Patents by Inventor Yuxiao Wang

Yuxiao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090663
    Abstract: Compositions and methods for binding to target antigens. Compositions comprising variable heavy chain domains with binding specificity to CD70, GPC3, IL13Ralpha2 and Cadherin CDH17 antigens.
    Type: Application
    Filed: September 13, 2024
    Publication date: March 20, 2025
    Inventors: Daniel Getts, Yuxiao Wang, Vania Emilova Ashminova, Thach Chu
  • Patent number: 12252545
    Abstract: The present disclosure provides compositions and methods for making and using engineered killer phagocytic cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, the chimeric receptor is encoded by a recombinant nucleic acid.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: March 18, 2025
    Assignee: MYELOID THERAPEUTICS, INC.
    Inventors: Daniel Getts, Yuxiao Wang
  • Publication number: 20240391998
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Application
    Filed: May 24, 2024
    Publication date: November 28, 2024
    Inventors: Daniel Getts, Yuxiao Wang
  • Publication number: 20240327482
    Abstract: Compositions and methods for making and using therapeutic agents comprising myeloid cell specific engagers, used for immunotherapy of cancer or infection.
    Type: Application
    Filed: March 8, 2024
    Publication date: October 3, 2024
    Inventors: Daniel Getts, Yuxiao Wang, Bruce McCreedy, Jr.
  • Publication number: 20240252630
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Application
    Filed: February 6, 2024
    Publication date: August 1, 2024
    Inventors: Daniel Getts, Yuxiao Wang, Bruce McCreedy, Jr.
  • Patent number: 12030938
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: July 9, 2024
    Assignee: MYELOID THERAPEUTICS, INC.
    Inventors: Daniel Getts, Yuxiao Wang
  • Publication number: 20240182543
    Abstract: Compositions and methods for making and using engineered myeloid cells that express a chimeric fusion protein for immunotherapy and compositions and methods for making and using engineered T cells that express a chimeric antigen receptor for immunotherapy.
    Type: Application
    Filed: November 21, 2023
    Publication date: June 6, 2024
    Inventors: Daniel GETTS, Yuxiao WANG
  • Publication number: 20240179377
    Abstract: Embodiments of the present disclosure provide a multimedia object sharing method, an electronic device, and a storage medium, wherein the method includes: displaying a multimedia list creation page, in response to a trigger operation for multimedia list creation, to edit associated content corresponding to a multimedia list to be shared in the multimedia list creation page; displaying an information editing page to determine a target sharing user and a target shared object in the multimedia list to be shared based on a trigger operation on the information editing page; and sharing the multimedia list to be shared to the target sharing user.
    Type: Application
    Filed: November 28, 2023
    Publication date: May 30, 2024
    Inventors: Yuxiao WANG, Ziyou ZENG, Yujie QIAN
  • Publication number: 20240177249
    Abstract: The embodiment of the disclosure provides an interaction method based on multimedia objects, device, electronic apparatus and a storage medium. The method includes: displaying user identification information of at least one target user in a display interface; the target user is a user who posts a target multimedia object; determining a display mode of a target multimedia object corresponding to a triggered user identification information based on a triggering operation on the user identification information and a posting state of a current user; and displaying the target multimedia object based on the display mode.
    Type: Application
    Filed: November 28, 2023
    Publication date: May 30, 2024
    Inventors: Yuxiao WANG, Guanyuan PENG
  • Publication number: 20240139314
    Abstract: The present disclosure provides compositions and methods for making and using engineered myeloid cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, wherein the chimeric receptor is encoded by a recombinant nucleic acid.
    Type: Application
    Filed: October 13, 2023
    Publication date: May 2, 2024
    Inventors: Daniel GETTS, Yuxiao WANG
  • Patent number: 11944680
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Grant
    Filed: January 18, 2023
    Date of Patent: April 2, 2024
    Assignee: MYELOID THERAPEUTICS, INC.
    Inventors: Daniel Getts, Yuxiao Wang, Bruce McCreedy, Jr.
  • Patent number: 11924337
    Abstract: An aspect of the present invention is provided with a sensitive data protection code generating unit which generates a sensitive data protection code of a predetermined data length, a symmetric encryption key generating unit which generates a symmetric encryption key by using a key derivation function that takes, as input, the sensitive data protection code, a sensitive data encrypting unit which encrypts sensitive data by using the symmetric encryption key, a sensitive data protection code encrypting unit which encrypts the sensitive data protection code by using a public key provided from an sensitive data access support terminal, and a deleting unit which deletes the symmetric encryption key and the sensitive data after the encryption of the sensitive data, and deletes the sensitive data protection code after the encryption of the sensitive data protection code.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: March 5, 2024
    Assignee: Soliton Systems K.K.
    Inventors: Bo Stig Hansen, Emil Mourier, Kiril Georgiev Georgiev, Thomas Hermann Wang-Nielsen, Yuxiao Wang
  • Publication number: 20230374538
    Abstract: Compositions and methods for making and using engineered phagocytic cells that express a chimeric antigen receptor having an enhanced phagocytic activity for stable and durable expression are described and can be suitably used for immunotherapy in cancer or infection.
    Type: Application
    Filed: March 22, 2023
    Publication date: November 23, 2023
    Inventors: Daniel GETTS, Yuxiao WANG, Namita BISARIA, Inna SHCHERBAKOVA, William F. ROWLEY, JR.
  • Publication number: 20230364265
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: May 5, 2023
    Publication date: November 16, 2023
    Inventors: Daniel GETTS, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • Publication number: 20230364266
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: May 5, 2023
    Publication date: November 16, 2023
    Inventors: Daniel GETTS, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • Publication number: 20230303684
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Application
    Filed: January 20, 2023
    Publication date: September 28, 2023
    Inventors: Daniel Getts, Yuxiao Wang
  • Publication number: 20230277659
    Abstract: Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
    Type: Application
    Filed: January 18, 2023
    Publication date: September 7, 2023
    Inventors: Daniel Getts, Yuxiao Wang, Bruce McCreedy, JR.
  • Publication number: 20230224236
    Abstract: A routing information transmission method includes before forwarding a service traffic packet, a first network device receives first Border Gateway Protocol (BGP) routing information from a second network device to determine a first forwarding table entry based on a service identifier and an identifier of a first network slice that are in the first BGP routing information. The first forwarding table entry indicates to forward, to the second network device using the first network slice, the service traffic. When receiving the service traffic packet corresponding to the service identifier, the first network device determines the first network slice based on the first forwarding table entry, and then sends the service traffic to the second network device using the first network slice.
    Type: Application
    Filed: March 21, 2023
    Publication date: July 13, 2023
    Inventors: Yanrong Liang, Guoqi Xu, Yuxiao Wang
  • Patent number: 11672874
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: June 13, 2023
    Assignee: MYELOID THERAPEUTICS, INC.
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • Patent number: D1028341
    Type: Grant
    Filed: July 4, 2022
    Date of Patent: May 21, 2024
    Inventor: Yuxiao Wang